Peter Cimermancic is a biotech research leader and co-founder with 12 years of experience applying computational and structural biology, genomics, and proteomics to therapeutic target discovery and modulation. He led pathology machine-learning efforts at Verily and founded Tesorai after co-founding Adrix Therapeutics, combining hands-on method development with entrepreneurship. His work spans novel ML and statistical methods, integrative structural modeling, and practical drug-discovery pipelines—examples include ClusterFinder for biosynthetic gene clusters and CryptoSite for hidden binding-site prediction used by pharma. He has a track record of turning large, noisy datasets into actionable hypotheses and has coordinated multi-lab discovery programs that advanced small-molecule leads to in vivo proof-of-concept. Based in San Francisco with a PhD from UCSF, he blends deep computational expertise with wet-lab collaborations and a knack for translating complex biology into therapeutic strategies.
12 years of coding experience
9 years of employment as a software developer
BS Biochemistry, BS Biochemistry at University of Ljubljana
PhD Biomedical Informatics, PhD Biomedical Informatics at University of California, San Francisco
Contributions:8 commits, 2 comments, 1 issue in 1 day
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.